Showing results (391-400 of 495) with videos related to

Sort By:
Pageof 50
Pediatrics|September 22, 2021
IVIG Compared With IVIG Plus Infliximab in Multisystem Inflammatory Syndrome in ChildrenLyndsey D Cole, Christina M Osborne, Lori J Silveira, et al.
Dynamic Medicine : DM|April 23, 2008
Percent body fat estimations in college men using field and laboratory methods: a three-compartment model approachJordan R Moon, Sarah E Tobkin, Abbie E Smith, et al.
The Science of the Total Environment|April 18, 2013
Predicting the contribution of nanoparticles (Zn, Ti, Ag) to the annual metal load in the Dutch reaches of the Rhine and MeuseA A Markus, J R Parsons, E W M Roex, et al.
The Journal of Antimicrobial Chemotherapy|June 1, 1995
Chemotherapeutic activity of levofloxacin (HR 355, DR-3355) against systemic and localized infections in laboratory animalsN Klesel, K H Geweniger, P Koletzki, et al.
Archives of Pathology & Laboratory Medicine|March 19, 2026
Factors Influencing Choice of Laboratory-Developed Tests and US Food and Drug Administration (FDA)-Approved or FDA-Cleared In Vitro Diagnostics for Molecular AnalytesBenjamin F Smith, Julia A Bridge, Susan J Hsiao, et al.
Nutrition & Metabolism|December 17, 2013
Effects of oral adenosine-5'-triphosphate supplementation on athletic performance, skeletal muscle hypertrophy and recovery in resistance-trained menJacob M Wilson, Jordan M Joy, Ryan P Lowery, et al.
The Journal of Antibiotics|April 1, 1992
RU 29 246, the active compound of the cephalosporin-prodrug-ester HR 916. I. Antibacterial activity in vitroA Bauernfeind, R Jungwirth, E Eberlein, et al.
The Journal of Antibiotics|December 2, 1999
Ala(0)-actagardine, a new lantibiotic from cultures of Actinoplanes liguriae ATCC 31048L Vértesy, W Aretz, A Bonnefoy, et al.
Rofo : Fortschritte Auf Dem Gebiete Der Rontgenstrahlen Und Der Nuklearmedizin|May 7, 1999
[1H-MR spectroscopy in anorexia nervosa: the characteristic differences between patients and healthy subjects]J Hentschel, R Möckel, H P Schlemmer, et al.
The Journal of Antibiotics|April 1, 1992
RU 29 246, the active compound of the cephalosporin-prodrug-ester HR 916. II. Stability to beta-lactamases and affinity for penicillin-binding proteinsA Markus, N Klesel, T Wollmann, et al.
Pageof 50